Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zimin Liu

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Journal of Gastric Cancer|July 7, 2026
Optimizing Postoperative Management in Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Gastroesophageal Junction Adenocarcinoma: A Multicenter Retrospective StudyHua Liu, Hongmei Xu, Yakun Wang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 27, 2018
Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort studyXinhua Zhang, Ye Zhou, Xin Wu, et al.
The Oncologist|February 13, 2023
Activity of Anlotinib in the Second-Line Therapy of Metastatic Gastrointestinal Stromal Tumors: A Prospective, Multicenter, In Vitro StudyYongjian Zhou, Chunling Zeng, Xiaofeng Sun, et al.
Frontiers in Immunology|January 29, 2026
Survival and multi-omics analysis of immunotherapy-based conversion treatment for initially unresectable gastric cancerSong Li, Qian Xu, Wenbin Yu, et al.
Annals of Surgical Oncology|November 5, 2023
Deep Learning Radiomics Nomogram Based on Enhanced CT to Predict the Response of Metastatic Lymph Nodes to Neoadjuvant Chemotherapy in Locally Advanced Gastric CancerHao Zhong, Tongyu Wang, Mingyu Hou, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 7, 2025
Development and validation of a machine learning model for predicting immune checkpoint inhibitor efficacy in advanced gastric cancer using dynamic changes in peripheral blood clinlabomics data: a retrospective multicenter cohort studyShulun Nie, Shuyi Song, Qian Xu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 7, 2018
A multi-center survey on dietary knowledge and behavior among inpatients in oncology departmentMinghua Cong, Jiejun Wang, Yu Fang, et al.
Cancers|October 27, 2022
The Optimal Therapy after Progression on Immune Checkpoint Inhibitors in MSI Metastatic Gastrointestinal Cancer Patients: A Multicenter Retrospective Cohort StudyMifen Chen, Zhenghang Wang, Zimin Liu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 23, 2026
The whole-course of supervised home-based multi-modal prehabilitation to improve clinical outcome in patients undergoing neoadjuvant chemotherapy prior to gastrectomy: a single-center randomized controlled trialQi Liu, Cheng Meng, Shougen Cao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2026
First-Line Disitamab Vedotin, Tislelizumab, and S-1 in HER2-Overexpressing Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Arm, Phase II TrialSong Li, Zimin Liu, Yanguo Liu, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of Gastric Cancer|July 7, 2026
Optimizing Postoperative Management in Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Gastroesophageal Junction Adenocarcinoma: A Multicenter Retrospective StudyHua Liu, Hongmei Xu, Yakun Wang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 27, 2018
Cytoreductive surgery for metastatic gastrointestinal stromal tumors followed by sunitinib compared to followed by imatinib-a multi-center cohort studyXinhua Zhang, Ye Zhou, Xin Wu, et al.
The Oncologist|February 13, 2023
Activity of Anlotinib in the Second-Line Therapy of Metastatic Gastrointestinal Stromal Tumors: A Prospective, Multicenter, In Vitro StudyYongjian Zhou, Chunling Zeng, Xiaofeng Sun, et al.
Frontiers in Immunology|January 29, 2026
Survival and multi-omics analysis of immunotherapy-based conversion treatment for initially unresectable gastric cancerSong Li, Qian Xu, Wenbin Yu, et al.
Annals of Surgical Oncology|November 5, 2023
Deep Learning Radiomics Nomogram Based on Enhanced CT to Predict the Response of Metastatic Lymph Nodes to Neoadjuvant Chemotherapy in Locally Advanced Gastric CancerHao Zhong, Tongyu Wang, Mingyu Hou, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 7, 2025
Development and validation of a machine learning model for predicting immune checkpoint inhibitor efficacy in advanced gastric cancer using dynamic changes in peripheral blood clinlabomics data: a retrospective multicenter cohort studyShulun Nie, Shuyi Song, Qian Xu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 7, 2018
A multi-center survey on dietary knowledge and behavior among inpatients in oncology departmentMinghua Cong, Jiejun Wang, Yu Fang, et al.
Cancers|October 27, 2022
The Optimal Therapy after Progression on Immune Checkpoint Inhibitors in MSI Metastatic Gastrointestinal Cancer Patients: A Multicenter Retrospective Cohort StudyMifen Chen, Zhenghang Wang, Zimin Liu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 23, 2026
The whole-course of supervised home-based multi-modal prehabilitation to improve clinical outcome in patients undergoing neoadjuvant chemotherapy prior to gastrectomy: a single-center randomized controlled trialQi Liu, Cheng Meng, Shougen Cao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2026
First-Line Disitamab Vedotin, Tislelizumab, and S-1 in HER2-Overexpressing Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Arm, Phase II TrialSong Li, Zimin Liu, Yanguo Liu, et al.
Pageof 7